Alisia Cesta

429 total citations
20 papers, 339 citations indexed

About

Alisia Cesta is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alisia Cesta has authored 20 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alisia Cesta's work include Cancer Immunotherapy and Biomarkers (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Chemokine receptors and signaling (3 papers). Alisia Cesta is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Chemokine receptors and signaling (3 papers). Alisia Cesta collaborates with scholars based in Italy, Iran and Colombia. Alisia Cesta's co-authors include F. Recchia, Silvio Rea, Gaetano Saggio, Giampiero Candeloro, Anna Di Blasio, Antonio Nuzzo, Stefano Necozione, G Carta, Edoardo Alesse and Marco Lombardo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Alisia Cesta

20 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alisia Cesta Italy 11 192 104 85 60 60 20 339
Giampiero Candeloro Italy 10 171 0.9× 104 1.0× 98 1.2× 73 1.2× 47 0.8× 33 333
Gaetano Saggio Italy 13 210 1.1× 188 1.8× 144 1.7× 71 1.2× 70 1.2× 28 468
G. Rangoni Italy 10 111 0.6× 143 1.4× 36 0.4× 14 0.2× 68 1.1× 26 362
Gairin Dancey United Kingdom 6 58 0.3× 80 0.8× 42 0.5× 20 0.3× 43 0.7× 9 227
Akira Yabuno Japan 11 79 0.4× 123 1.2× 26 0.3× 30 0.5× 51 0.8× 37 322
Eunice H. Rhee United States 5 133 0.7× 146 1.4× 13 0.2× 106 1.8× 85 1.4× 5 403
Giulia Dondi Italy 11 45 0.2× 223 2.1× 78 0.9× 20 0.3× 46 0.8× 31 402
C. Madroñal Spain 4 153 0.8× 446 4.3× 48 0.6× 17 0.3× 88 1.5× 11 533
Jennifer Ducie United States 13 81 0.4× 409 3.9× 41 0.5× 19 0.3× 62 1.0× 16 630
Maria Grazia Cantù Italy 9 106 0.6× 437 4.2× 183 2.2× 20 0.3× 47 0.8× 16 574

Countries citing papers authored by Alisia Cesta

Since Specialization
Citations

This map shows the geographic impact of Alisia Cesta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alisia Cesta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alisia Cesta more than expected).

Fields of papers citing papers by Alisia Cesta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alisia Cesta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alisia Cesta. The network helps show where Alisia Cesta may publish in the future.

Co-authorship network of co-authors of Alisia Cesta

This figure shows the co-authorship network connecting the top 25 collaborators of Alisia Cesta. A scholar is included among the top collaborators of Alisia Cesta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alisia Cesta. Alisia Cesta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Recchia, F., Giampiero Candeloro, Alisia Cesta, et al.. (2014). Anthracycline-based induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5-fluorouracil and radiation therapy in surgically resected axillary node-positive breast cancer. Molecular and Clinical Oncology. 2(3). 473–478. 1 indexed citations
2.
Recchia, F., Giampiero Candeloro, Stefano Necozione, et al.. (2013). Vascular endothelial growth factor expression and T-regulatory cells in premenopausal breast cancer. Oncology Letters. 5(4). 1117–1122. 4 indexed citations
3.
Recchia, F., Giampiero Candeloro, Alisia Cesta, et al.. (2013). Abstract 480: Maintenance immunotherapy following carboplatin (CBDCA) - pemetrexed (PEM) chemotherapy in advanced adenocarcinoma (ADK) of the lung: A phase II study.. Cancer Research. 73(8_Supplement). 480–480. 1 indexed citations
4.
Biondi, Edoardo, et al.. (2008). Paralytic Ileus Associated with Capecitabine. Tumori Journal. 94(5). 742–745. 3 indexed citations
5.
Recchia, F., Gaetano Saggio, Anna Di Blasio, et al.. (2007). A multicenter phase II study of pegylated liposomal doxorubicin and oxaliplatin in recurrent ovarian cancer. Gynecologic Oncology. 106(1). 164–169. 19 indexed citations
6.
Recchia, F., Gaetano Saggio, Anna Di Blasio, et al.. (2007). Multicenter Phase II Study of Chemo-immunotherapy in the Treatment of Metastatic Renal Cell Carcinoma. Journal of Immunotherapy. 30(4). 448–454. 10 indexed citations
7.
Recchia, F., Gaetano Saggio, Giampiero Candeloro, et al.. (2007). Chemoimmunotherapy in the treatment of metastatic gastric cancer. Anti-Cancer Drugs. 18(5). 597–604. 6 indexed citations
8.
Recchia, F., Gaetano Saggio, Alisia Cesta, et al.. (2006). Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.. PubMed. 26(3B). 2317–24. 3 indexed citations
9.
Recchia, F., Gaetano Saggio, Alisia Cesta, et al.. (2006). Phase II study of interleukin-2 and 13-cis-retinoic acid as maintenance therapy in metastatic colorectal cancer. Cancer Immunology Immunotherapy. 56(5). 699–708. 23 indexed citations
10.
11.
Recchia, F., Gaetano Saggio, Alisia Cesta, et al.. (2006). Cardiac Metastases in Malignant Fibrous Histiocytoma. A Case Report. Tumori Journal. 92(1). 76–78. 7 indexed citations
12.
Mattioli, Rodolfo, Cristian Massacesi, F. Recchia, et al.. (2005). High activity and reduced neurotoxicity of bi-fractionated oxaliplatin plus 5-fluorouracil/leucovorin for elderly patients with advanced colorectal cancer. Annals of Oncology. 16(7). 1147–1151. 40 indexed citations
13.
14.
Recchia, F., Gaetano Saggio, Alisia Cesta, Giampiero Candeloro, & Silvio Rea. (2005). Paclitaxel plus gemcitabine in advanced non-small cell lung cancer patients with low performance status.. PubMed. 25(1B). 409–14. 5 indexed citations
15.
Recchia, F., Gaetano Saggio, Antonio Nuzzo, et al.. (2005). Multicenter Phase 2 Study of Interleukin-2 and 13-Cis Retinoic Acid as Maintenance Therapy in Advanced Non-Small-Cell Lung Cancer. Journal of Immunotherapy. 29(1). 87–94. 23 indexed citations
16.
Recchia, F., Gaetano Saggio, Alisia Cesta, et al.. (2005). Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy.. PubMed. 25(4). 3149–57. 16 indexed citations
17.
Recchia, F., Gaetano Saggio, Alisia Cesta, et al.. (2005). Interleukin-2 and 13-cis retinoic acid as maintenance therapy in advanced ovarian cancer. International Journal of Oncology. 27(4). 1039–46. 27 indexed citations
18.
Recchia, F., Gaetano Saggio, Antonio Nuzzo, et al.. (2004). Multicentre phase II study of bifractionated CPT-11 with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with FOLFOX. British Journal of Cancer. 91(8). 1442–1446. 12 indexed citations
19.
Recchia, F., et al.. (2003). Phase I study of liposomal doxorubicin and oxaliplatin as salvage chemotherapy in advanced ovarian cancer. Anti-Cancer Drugs. 14(8). 633–638. 18 indexed citations
20.
Recchia, F., et al.. (2001). Phase 1B study of subcutaneously administered interleukin 2 in combination with 13-cis retinoic acid as maintenance therapy in advanced cancer.. PubMed. 7(5). 1251–7. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giampiero Candeloro Breakdown of academic impact, for papers by Gaetano Saggio Breakdown of academic impact, for papers by G. Rangoni Breakdown of academic impact, for papers by Gairin Dancey Breakdown of academic impact, for papers by Akira Yabuno Breakdown of academic impact, for papers by Eunice H. Rhee Breakdown of academic impact, for papers by Giulia Dondi Breakdown of academic impact, for papers by C. Madroñal Breakdown of academic impact, for papers by Jennifer Ducie Breakdown of academic impact, for papers by Maria Grazia Cantù
Rankless by CCL
2026